Current experimental and early investigational agents for cardiac fibrosis: where are we at?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current experimental and early investigational agents for cardiac fibrosis: where are we at?

Published:2024-03-06 Issue:4 Volume:33 Page:389-404
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ciampi Claudio M.¹,Sultana Andrea¹,Ossola Paolo¹,Farina Andrea²,Fragasso Gabriele³,Spoladore Roberto²

Affiliation:

1. Health Science Department, University of Milan Bicocca, Milano, Italy

2. Division of Cardiology, Alessandro Manzoni Hospital, ASST- Lecco, Italy

3. Heart Failure Unit Head, Division of Cardiology, IRCCS Vita-Salute San Raffaele University Hospital, Milan, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2326024

Reference148 articles.

1. Matricellular proteins in the heart: possible role during stress and remodeling

2. Cellular and molecular mechanisms of fibrosis

3. Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis

4. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target

5. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP